Skip to main content
Top
Published in: Journal of Translational Medicine 1/2021

Open Access 01-12-2021 | Osteoarthrosis | Research

Identification and development of a novel 5-gene diagnostic model based on immune infiltration analysis of osteoarthritis

Authors: YaGuang Han, Jun Wu, ZhenYu Gong, YiQin Zhou, HaoBo Li, Bo Wang, QiRong Qian

Published in: Journal of Translational Medicine | Issue 1/2021

Login to get access

Abstract

Background

Osteoarthritis (OA), which is due to the progressive loss and degeneration of articular cartilage, is the leading cause of disability worldwide. Therefore, it is of great significance to explore OA biomarkers for the prevention, diagnosis, and treatment of OA.

Methods and materials

The GSE129147, GSE57218, GSE51588, GSE117999, and GSE98918 datasets with normal and OA samples were downloaded from the Gene Expression Omnibus (GEO) database. The GSE117999 and GSE98918 datasets were integrated, and immune infiltration was evaluated. The differentially expressed genes (DEGs) were analyzed using the limma package in R, and weighted gene co-expression network analysis (WGCNA) was used to explore the co-expression genes and co-expression modules. The co-expression module genes were analyzed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. A protein–protein interaction (PPI) network was constructed using the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database, and hub genes were identified by the degree, MNC, closeness, and MCC algorithms. The hub genes were used to construct a diagnostic model based on support vector machines.

Results

The Immune Score in the OA samples was significantly higher than in the normal samples, and a total of 2313 DEGs were identified. Through WGCNA, we found that the yellow module was significantly positively correlated with the OA samples and Immune Score and negatively correlated with the normal samples. The 142 DEGs of the yellow module were related to biological processes such as regulation of inflammatory response, positive regulation of inflammatory response, blood vessel morphogenesis, endothelial cell migration, and humoral immune response. The intersections of the genes obtained by the 4 algorithms resulted in 5 final hub genes, and the diagnostic model constructed with these 5 genes showed good performance in the training and validation cohorts.

Conclusions

The 5-gene diagnostic model can be used to diagnose OA and guide clinical decision-making.
Appendix
Available only for authorised users
Literature
1.
go back to reference Yelin E, Weinstein S, King T. The burden of musculoskeletal diseases in the United States. Semin Arthritis Rheum. 2016;46(3):259–60.PubMed Yelin E, Weinstein S, King T. The burden of musculoskeletal diseases in the United States. Semin Arthritis Rheum. 2016;46(3):259–60.PubMed
2.
go back to reference Glyn-Jones S, et al. Osteoarthritis. Lancet. 2015;386(9991):376–87.PubMed Glyn-Jones S, et al. Osteoarthritis. Lancet. 2015;386(9991):376–87.PubMed
3.
go back to reference Mobasheri A. The future of osteoarthritis therapeutics: emerging biological therapy. Curr Rheumatol Rep. 2013;15(12):385.PubMedPubMedCentral Mobasheri A. The future of osteoarthritis therapeutics: emerging biological therapy. Curr Rheumatol Rep. 2013;15(12):385.PubMedPubMedCentral
4.
go back to reference Kim JR, Yoo JJ, Kim HA. Therapeutics in osteoarthritis based on an understanding of its molecular pathogenesis. Int J Mol Sci. 2018;19(3):674.PubMedCentral Kim JR, Yoo JJ, Kim HA. Therapeutics in osteoarthritis based on an understanding of its molecular pathogenesis. Int J Mol Sci. 2018;19(3):674.PubMedCentral
5.
go back to reference Ma T, et al. Combined detection of COMP and CS846 biomarkers in experimental rat osteoarthritis: a potential approach for assessment and diagnosis of osteoarthritis. J Orthop Surg Res. 2018;13(1):230.PubMedPubMedCentral Ma T, et al. Combined detection of COMP and CS846 biomarkers in experimental rat osteoarthritis: a potential approach for assessment and diagnosis of osteoarthritis. J Orthop Surg Res. 2018;13(1):230.PubMedPubMedCentral
6.
go back to reference Nguyen LT, et al. Review of prospects of biological fluid biomarkers in osteoarthritis. Int J Mol Sci. 2017;18(3):601.PubMedCentral Nguyen LT, et al. Review of prospects of biological fluid biomarkers in osteoarthritis. Int J Mol Sci. 2017;18(3):601.PubMedCentral
7.
go back to reference Hosnijeh FS, et al. Biomarkers for osteoarthritis: can they be used for risk assessment? A systematic review. Maturitas. 2015;82(1):36–49.PubMed Hosnijeh FS, et al. Biomarkers for osteoarthritis: can they be used for risk assessment? A systematic review. Maturitas. 2015;82(1):36–49.PubMed
8.
go back to reference Mobasheri A, et al. Osteoarthritis year in review 2016: biomarkers (biochemical markers). Osteoarthritis Cartil. 2017;25(2):199–208. Mobasheri A, et al. Osteoarthritis year in review 2016: biomarkers (biochemical markers). Osteoarthritis Cartil. 2017;25(2):199–208.
9.
go back to reference Loeser RF, et al. Association of urinary metabolites with radiographic progression of knee osteoarthritis in overweight and obese adults: an exploratory study. Osteoarthritis Cartil. 2016;24(8):1479–86. Loeser RF, et al. Association of urinary metabolites with radiographic progression of knee osteoarthritis in overweight and obese adults: an exploratory study. Osteoarthritis Cartil. 2016;24(8):1479–86.
10.
go back to reference Asik MD, et al. Microarray analysis of cartilage: comparison between damaged and non-weight-bearing healthy cartilage. Connect Tissue Res. 2020;61(5):456–64.PubMed Asik MD, et al. Microarray analysis of cartilage: comparison between damaged and non-weight-bearing healthy cartilage. Connect Tissue Res. 2020;61(5):456–64.PubMed
11.
go back to reference Ramos YF, et al. Genes involved in the osteoarthritis process identified through genome wide expression analysis in articular cartilage; the RAAK study. PLoS ONE. 2014;9(7):e103056.PubMedPubMedCentral Ramos YF, et al. Genes involved in the osteoarthritis process identified through genome wide expression analysis in articular cartilage; the RAAK study. PLoS ONE. 2014;9(7):e103056.PubMedPubMedCentral
12.
go back to reference Chou CH, et al. Genome-wide expression profiles of subchondral bone in osteoarthritis. Arthritis Res Ther. 2013;15(6):R190.PubMedPubMedCentral Chou CH, et al. Genome-wide expression profiles of subchondral bone in osteoarthritis. Arthritis Res Ther. 2013;15(6):R190.PubMedPubMedCentral
13.
go back to reference Brophy RH, et al. Transcriptome comparison of meniscus from patients with and without osteoarthritis. Osteoarthritis Cartil. 2018;26(3):422–32. Brophy RH, et al. Transcriptome comparison of meniscus from patients with and without osteoarthritis. Osteoarthritis Cartil. 2018;26(3):422–32.
14.
go back to reference Aref-Eshghi E, et al. Genome-wide DNA methylation study of hip and knee cartilage reveals embryonic organ and skeletal system morphogenesis as major pathways involved in osteoarthritis. BMC Musculoskelet Disord. 2015;16:287.PubMedPubMedCentral Aref-Eshghi E, et al. Genome-wide DNA methylation study of hip and knee cartilage reveals embryonic organ and skeletal system morphogenesis as major pathways involved in osteoarthritis. BMC Musculoskelet Disord. 2015;16:287.PubMedPubMedCentral
16.
go back to reference Madaleno FO, et al. Prevalence of knee osteoarthritis in former athletes: a systematic review with meta-analysis. Braz J Phys Ther. 2018;22(6):437–51.PubMedPubMedCentral Madaleno FO, et al. Prevalence of knee osteoarthritis in former athletes: a systematic review with meta-analysis. Braz J Phys Ther. 2018;22(6):437–51.PubMedPubMedCentral
17.
go back to reference French HP, et al. Exercise and manual physiotherapy arthritis research trial (EMPART) for osteoarthritis of the hip: a multicenter randomized controlled trial. Arch Phys Med Rehabil. 2013;94(2):302–14.PubMed French HP, et al. Exercise and manual physiotherapy arthritis research trial (EMPART) for osteoarthritis of the hip: a multicenter randomized controlled trial. Arch Phys Med Rehabil. 2013;94(2):302–14.PubMed
18.
go back to reference Jones G, et al. Early radiographic osteoarthritis is associated with substantial changes in cartilage volume and tibial bone surface area in both males and females. Osteoarthritis Cartilage. 2004;12(2):169–74.PubMed Jones G, et al. Early radiographic osteoarthritis is associated with substantial changes in cartilage volume and tibial bone surface area in both males and females. Osteoarthritis Cartilage. 2004;12(2):169–74.PubMed
19.
go back to reference Usenbo A, et al. Prevalence of arthritis in Africa: a systematic review and meta-analysis. PLoS ONE. 2015;10(8):e0133858.PubMedPubMedCentral Usenbo A, et al. Prevalence of arthritis in Africa: a systematic review and meta-analysis. PLoS ONE. 2015;10(8):e0133858.PubMedPubMedCentral
20.
go back to reference Scotece M, et al. Oleocanthal inhibits catabolic and inflammatory mediators in LPS-activated human primary osteoarthritis (OA) chondrocytes through MAPKs/NF-kappaB pathways. Cell Physiol Biochem. 2018;49(6):2414–26.PubMed Scotece M, et al. Oleocanthal inhibits catabolic and inflammatory mediators in LPS-activated human primary osteoarthritis (OA) chondrocytes through MAPKs/NF-kappaB pathways. Cell Physiol Biochem. 2018;49(6):2414–26.PubMed
21.
go back to reference Cao J, et al. miR-940 regulates the inflammatory response of chondrocytes by targeting MyD88 in osteoarthritis. Mol Cell Biochem. 2019;461(1–2):183–93.PubMed Cao J, et al. miR-940 regulates the inflammatory response of chondrocytes by targeting MyD88 in osteoarthritis. Mol Cell Biochem. 2019;461(1–2):183–93.PubMed
22.
go back to reference Chen Q, et al. MiR-149 suppresses the inflammatory response of chondrocytes in osteoarthritis by down-regulating the activation of TAK1/NF-kappaB. Biomed Pharmacother. 2018;101:763–8.PubMed Chen Q, et al. MiR-149 suppresses the inflammatory response of chondrocytes in osteoarthritis by down-regulating the activation of TAK1/NF-kappaB. Biomed Pharmacother. 2018;101:763–8.PubMed
23.
go back to reference Li Y, et al. Artesunate alleviates interleukin1betainduced inflammatory response and apoptosis by inhibiting the NFkappaB signaling pathway in chondrocytelike ATDC5 cells, and delays the progression of osteoarthritis in a mouse model. Int J Mol Med. 2019;44(4):1541–51.PubMed Li Y, et al. Artesunate alleviates interleukin1betainduced inflammatory response and apoptosis by inhibiting the NFkappaB signaling pathway in chondrocytelike ATDC5 cells, and delays the progression of osteoarthritis in a mouse model. Int J Mol Med. 2019;44(4):1541–51.PubMed
24.
go back to reference Walsh DA, et al. Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis. Rheumatology. 2010;49(10):1852–61.PubMedPubMedCentral Walsh DA, et al. Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis. Rheumatology. 2010;49(10):1852–61.PubMedPubMedCentral
25.
go back to reference Mahjoub M, Berenbaum F, Houard X. Why subchondral bone in osteoarthritis? The importance of the cartilage bone interface in osteoarthritis. Osteoporos Int. 2012;23(Suppl 8):S841–6.PubMed Mahjoub M, Berenbaum F, Houard X. Why subchondral bone in osteoarthritis? The importance of the cartilage bone interface in osteoarthritis. Osteoporos Int. 2012;23(Suppl 8):S841–6.PubMed
26.
go back to reference Suri S, Walsh DA. Osteochondral alterations in osteoarthritis. Bone. 2012;51(2):204–11.PubMed Suri S, Walsh DA. Osteochondral alterations in osteoarthritis. Bone. 2012;51(2):204–11.PubMed
27.
go back to reference Mapp PI, et al. Angiogenesis in two animal models of osteoarthritis. Osteoarthritis Cartil. 2008;16(1):61–9. Mapp PI, et al. Angiogenesis in two animal models of osteoarthritis. Osteoarthritis Cartil. 2008;16(1):61–9.
28.
go back to reference Mapp PI, Walsh DA. Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis. Nat Rev Rheumatol. 2012;8(7):390–8.PubMed Mapp PI, Walsh DA. Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis. Nat Rev Rheumatol. 2012;8(7):390–8.PubMed
29.
go back to reference Yu X, et al. NGF increases FGF2 expression and promotes endothelial cell migration and tube formation through PI3K/Akt and ERK/MAPK pathways in human chondrocytes. Osteoarthritis Cartil. 2019;27(3):526–34. Yu X, et al. NGF increases FGF2 expression and promotes endothelial cell migration and tube formation through PI3K/Akt and ERK/MAPK pathways in human chondrocytes. Osteoarthritis Cartil. 2019;27(3):526–34.
30.
go back to reference Liao W, et al. Proteomic analysis of synovial fluid in osteoarthritis using SWATHmass spectrometry. Mol Med Rep. 2018;17(2):2827–36.PubMed Liao W, et al. Proteomic analysis of synovial fluid in osteoarthritis using SWATHmass spectrometry. Mol Med Rep. 2018;17(2):2827–36.PubMed
31.
go back to reference Lin J, et al. Bioinformatics analysis to identify key genes and pathways influencing synovial inflammation in osteoarthritis. Mol Med Rep. 2018;18(6):5594–602.PubMedPubMedCentral Lin J, et al. Bioinformatics analysis to identify key genes and pathways influencing synovial inflammation in osteoarthritis. Mol Med Rep. 2018;18(6):5594–602.PubMedPubMedCentral
32.
go back to reference Qi X, et al. Integration of transcriptome-wide association study and messenger RNA expression profile to identify genes associated with osteoarthritis. Bone Joint Res. 2020;9(3):130–8.PubMedPubMedCentral Qi X, et al. Integration of transcriptome-wide association study and messenger RNA expression profile to identify genes associated with osteoarthritis. Bone Joint Res. 2020;9(3):130–8.PubMedPubMedCentral
33.
go back to reference Zhang Y, et al. NF-kappaB promotes osteoclast differentiation by overexpressing MITF via down regulating microRNA-1276 expression. Life Sci. 2020;258:118093.PubMed Zhang Y, et al. NF-kappaB promotes osteoclast differentiation by overexpressing MITF via down regulating microRNA-1276 expression. Life Sci. 2020;258:118093.PubMed
34.
go back to reference Durand M, et al. Monocytes from patients with osteoarthritis display increased osteoclastogenesis and bone resorption: the in vitro osteoclast differentiation in Arthritis study. Arthritis Rheum. 2013;65(1):148–58.PubMed Durand M, et al. Monocytes from patients with osteoarthritis display increased osteoclastogenesis and bone resorption: the in vitro osteoclast differentiation in Arthritis study. Arthritis Rheum. 2013;65(1):148–58.PubMed
35.
go back to reference Zhang Z, et al. Structural analysis reveals that toll-like receptor 7 is a dual receptor for guanosine and single-stranded RNA. Immunity. 2016;45(4):737–48.PubMed Zhang Z, et al. Structural analysis reveals that toll-like receptor 7 is a dual receptor for guanosine and single-stranded RNA. Immunity. 2016;45(4):737–48.PubMed
36.
go back to reference Lee J, et al. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7. Proc Natl Acad Sci USA. 2003;100(11):6646–51.PubMedPubMedCentral Lee J, et al. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7. Proc Natl Acad Sci USA. 2003;100(11):6646–51.PubMedPubMedCentral
37.
go back to reference Diebold SS, et al. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 2004;303(5663):1529–31.PubMed Diebold SS, et al. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 2004;303(5663):1529–31.PubMed
38.
go back to reference Hoshikawa N, et al. Targeting extracellular miR-21-TLR7 signaling provides long-lasting analgesia in osteoarthritis. Mol Ther Nucleic Acids. 2020;19:199–207.PubMed Hoshikawa N, et al. Targeting extracellular miR-21-TLR7 signaling provides long-lasting analgesia in osteoarthritis. Mol Ther Nucleic Acids. 2020;19:199–207.PubMed
39.
go back to reference Barreda DR, Hanington PC, Belosevic M. Regulation of myeloid development and function by colony stimulating factors. Dev Comp Immunol. 2004;28(5):509–54.PubMed Barreda DR, Hanington PC, Belosevic M. Regulation of myeloid development and function by colony stimulating factors. Dev Comp Immunol. 2004;28(5):509–54.PubMed
40.
go back to reference Wang XF, et al. Colony-stimulating factor 1 receptor inhibition prevents against lipopolysaccharide -induced osteoporosis by inhibiting osteoclast formation. Biomed Pharmacother. 2019;115:108916.PubMed Wang XF, et al. Colony-stimulating factor 1 receptor inhibition prevents against lipopolysaccharide -induced osteoporosis by inhibiting osteoclast formation. Biomed Pharmacother. 2019;115:108916.PubMed
41.
go back to reference Martinez-Martinez A, et al. Blockade of the colony-stimulating factor-1 receptor reverses bone loss in osteoporosis mouse models. Pharmacol Rep. 2020;72(6):1614–26.PubMed Martinez-Martinez A, et al. Blockade of the colony-stimulating factor-1 receptor reverses bone loss in osteoporosis mouse models. Pharmacol Rep. 2020;72(6):1614–26.PubMed
42.
go back to reference Rai MF, et al. Distinct degenerative phenotype of articular cartilage from knees with meniscus tear compared to knees with osteoarthritis. Osteoarthritis Cartil. 2019;27(6):945–55. Rai MF, et al. Distinct degenerative phenotype of articular cartilage from knees with meniscus tear compared to knees with osteoarthritis. Osteoarthritis Cartil. 2019;27(6):945–55.
43.
go back to reference Farnaghi S, et al. Protective effects of mitochondria-targeted antioxidants and statins on cholesterol-induced osteoarthritis. FASEB J. 2017;31(1):356–67.PubMed Farnaghi S, et al. Protective effects of mitochondria-targeted antioxidants and statins on cholesterol-induced osteoarthritis. FASEB J. 2017;31(1):356–67.PubMed
44.
go back to reference Melgar-Lesmes P, et al. Chondroitin sulphate attenuates atherosclerosis in ApoE knockout mice involving cellular regulation of the inflammatory response. Thromb Haemost. 2018;118(7):1329–39.PubMedPubMedCentral Melgar-Lesmes P, et al. Chondroitin sulphate attenuates atherosclerosis in ApoE knockout mice involving cellular regulation of the inflammatory response. Thromb Haemost. 2018;118(7):1329–39.PubMedPubMedCentral
45.
go back to reference Krimbou L, et al. Molecular interactions between apoE and ABCA1: impact on apoE lipidation. J Lipid Res. 2004;45(5):839–48.PubMed Krimbou L, et al. Molecular interactions between apoE and ABCA1: impact on apoE lipidation. J Lipid Res. 2004;45(5):839–48.PubMed
46.
go back to reference Kockx M, Traini M, Kritharides L. Cell-specific production, secretion, and function of apolipoprotein E. J Mol Med (Berl). 2018;96(5):361–71. Kockx M, Traini M, Kritharides L. Cell-specific production, secretion, and function of apolipoprotein E. J Mol Med (Berl). 2018;96(5):361–71.
47.
go back to reference Huang Y, Mahley RW. Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer’s diseases. Neurobiol Dis. 2014;72:3–12.PubMed Huang Y, Mahley RW. Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer’s diseases. Neurobiol Dis. 2014;72:3–12.PubMed
48.
go back to reference Lubbers R, et al. Complement component C1q is produced by isolated articular chondrocytes. Osteoarthritis Cartil. 2020;28(5):675–84. Lubbers R, et al. Complement component C1q is produced by isolated articular chondrocytes. Osteoarthritis Cartil. 2020;28(5):675–84.
49.
go back to reference Son M, et al. Evidence for C1q-mediated crosslinking of CD33/LAIR-1 inhibitory immunoreceptors and biological control of CD33/LAIR-1 expression. Sci Rep. 2017;7(1):270.PubMedPubMedCentral Son M, et al. Evidence for C1q-mediated crosslinking of CD33/LAIR-1 inhibitory immunoreceptors and biological control of CD33/LAIR-1 expression. Sci Rep. 2017;7(1):270.PubMedPubMedCentral
50.
go back to reference Jacquet M, et al. C1q and mannose-binding lectin interact with CR1 in the same region on CCP24-25 modules. Front Immunol. 2018;9:453.PubMedPubMedCentral Jacquet M, et al. C1q and mannose-binding lectin interact with CR1 in the same region on CCP24-25 modules. Front Immunol. 2018;9:453.PubMedPubMedCentral
51.
go back to reference Aldinucci D, Colombatti A. The inflammatory chemokine CCL5 and cancer progression. Mediat Inflamm. 2014;2014:292376. Aldinucci D, Colombatti A. The inflammatory chemokine CCL5 and cancer progression. Mediat Inflamm. 2014;2014:292376.
52.
go back to reference Soria G, Ben-Baruch A. The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett. 2008;267(2):271–85.PubMed Soria G, Ben-Baruch A. The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett. 2008;267(2):271–85.PubMed
53.
go back to reference Pierzchala AW, Kusz DJ, Hajduk G. CXCL8 and CCL5 expression in synovial fluid and blood serum in patients with osteoarthritis of the knee. Arch Immunol Ther Exp. 2011;59(2):151–5. Pierzchala AW, Kusz DJ, Hajduk G. CXCL8 and CCL5 expression in synovial fluid and blood serum in patients with osteoarthritis of the knee. Arch Immunol Ther Exp. 2011;59(2):151–5.
54.
go back to reference Li WC, et al. Identification of differentially expressed genes in synovial tissue of rheumatoid arthritis and osteoarthritis in patients. J Cell Biochem. 2019;120(3):4533–44.PubMed Li WC, et al. Identification of differentially expressed genes in synovial tissue of rheumatoid arthritis and osteoarthritis in patients. J Cell Biochem. 2019;120(3):4533–44.PubMed
Metadata
Title
Identification and development of a novel 5-gene diagnostic model based on immune infiltration analysis of osteoarthritis
Authors
YaGuang Han
Jun Wu
ZhenYu Gong
YiQin Zhou
HaoBo Li
Bo Wang
QiRong Qian
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2021
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-021-03183-9

Other articles of this Issue 1/2021

Journal of Translational Medicine 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.